Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 292 across all filing types
Latest filing 2025-04-28 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended March 31, 2025' and is issued pursuant to SEBI regulations related to the monitoring of IPO proceeds. It contains detailed information on the utilization of IPO funds, deviations from the objects of the issue, and certifications considered by the monitoring agency. The report is comprehensive, includes financial data related to the IPO proceeds, and is prepared by a monitoring agency as per regulatory requirements. This type of document is a regulatory compliance report specifically monitoring the use of IPO proceeds, which aligns with the category of Regulatory Filings (RNS) as it is a regulatory compliance document and not a full annual or quarterly financial report, nor an earnings release or other specific report type. The document is not merely an announcement of a report but the report itself, and it is not an officer certification or attestation letter. Therefore, the best classification is Regulatory Filings (RNS).
2025-04-28 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is an analyst presentation and fact sheet related to the financial results for the quarter and financial year ended March 31, 2025. It includes detailed financial highlights, management commentary, segment performance, business highlights, and growth strategies. The document is about 15,000 characters long and contains substantive financial data and analysis, not just an announcement or a brief summary. It is not a full annual report (10-K) but rather a detailed presentation aimed at investors and analysts, focusing on financials, strategy, and market position. Therefore, the most appropriate classification is Investor Presentation (IP).
2025-04-28 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter and financial year ended March 31, 2025. It includes key financial highlights such as revenue, profit after tax, and growth percentages, but it is not a full detailed financial report. The document is addressed to stock exchanges and references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events including financial results. The document is relatively short (5011 characters) and is clearly labeled as a press release. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2025-04-28 English
Outcome of Board Meeting
Regulatory Filings
2025-04-28 English
Dividend
Regulatory Filings
2025-04-28 English
Dividend
Regulatory Filings
2025-04-28 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.